Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing transformative products that address medical conditions with significant unmet patient needs in the areas of oncology, autoimmune disorders, infectious diseases and neurological disorders. Our goal is to leverage our capabilities and resources to reach one million patients by 2030, positively impacting human health worldwide.
View Top Employees from Zai LabWebsite | http://www.zailaboratory.com |
Ticker | ZLAB |
Revenue | $260 million |
Funding | $1.4 billion |
Employees | 535 (370 on RocketReach) |
Founded | 2014 |
Address | Jinchuang Plaza 4560 Jinke Rd 4/f Bldg 1, Pudong, Shanghai 201210, CN |
Phone | +86 21 6163 2588 |
Fax | +86 21 6163 2570 |
Technologies |
JavaScript,
HTML,
PHP
+39 more
(view full list)
|
Industry | Biotechnology Research, Medical Devices & Equipment, Biotechnology, Manufacturing, Science and Engineering, Health Care, Information Technology, Pharmaceutical |
Web Rank | 2 Million |
Keywords | Biopharmaceuticals, Oncology, Autoimmune Disease, Infectious Disease, Neurological Care, China, United States, Global Health |
Competitors | BeiGene, Crystax Pharmaceuticals / Oryzon Genomics, MacroGenics, Inc., Seagen, Sorrento Therapeutics, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 33 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Zai Lab employee's phone or email?
The Zai Lab annual revenue was $260 million in 2024.
Hua Gong is the Senior Vice President, Global Head of Translational Medicine and Clinical Biomarker of Zai Lab.
370 people are employed at Zai Lab.
Zai Lab is based in Pudong, Shanghai.
The NAICS codes for Zai Lab are [325, 33, 32, 3254].
The SIC codes for Zai Lab are [28, 283].